Shionogi & Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shionogi & Co Ltd with three other
companies in this sector in Japan:
Mitsubishi Tanabe Pharma Corp
sales of 433.86 billion Japanese Yen [US$3.87 billion]
of which 71%
was Domestic Ethical Drug),
Ono Pharmaceutical Co Ltd
(261.84 billion Japanese Yen [US$2.34 billion]
of which 79%
was Products & Goods), and
Taisho Pharmaceutical Holdings Co Ltd
(280.09 billion Japanese Yen [US$2.50 billion]
of which 66%
During the year ended March of 2018, sales at
Shionogi & Co Ltd were ¥344.67 billion (US$3.07 billion).
a very small
increase of 1.7%
versus 2017, when the company's sales were ¥338.89 billion.
This was the third consecutive year of growth at Shionogi & Co Ltd.